These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26710657)

  • 1. Naltrexone alters the processing of social and emotional stimuli in healthy adults.
    Wardle MC; Bershad AK; de Wit H
    Soc Neurosci; 2016 Dec; 11(6):579-91. PubMed ID: 26710657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of buprenorphine on responses to social stimuli in healthy adults.
    Bershad AK; Seiden JA; de Wit H
    Psychoneuroendocrinology; 2016 Jan; 63():43-9. PubMed ID: 26409030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine reduced perceived anger from neutral and implicit emotional expressions.
    Løseth GE; Eikemo M; Isager P; Holmgren J; Laeng B; Vindenes V; Hjørnevik T; Leknes S
    Psychoneuroendocrinology; 2018 May; 91():123-131. PubMed ID: 29550675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone increases negatively-valenced facial responses to happy faces in female participants.
    Meier IM; Bos PA; Hamilton K; Stein DJ; van Honk J; Malcolm-Smith S
    Psychoneuroendocrinology; 2016 Dec; 74():65-68. PubMed ID: 27588701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
    Walsh SL; Chausmer AE; Strain EC; Bigelow GE
    Psychopharmacology (Berl); 2008 Jan; 196(1):143-55. PubMed ID: 17909753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone.
    Mallik A; Chanda ML; Levitin DJ
    Sci Rep; 2017 Feb; 7():41952. PubMed ID: 28176798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Buprenorphine on Responses to Emotional Stimuli in Individuals with a Range of Mood Symptomatology.
    Bershad AK; Ruiz NA; de Wit H
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):120-127. PubMed ID: 29025085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls.
    Mitchell JM; Tavares VC; Fields HL; D'Esposito M; Boettiger CA
    Neuropsychopharmacology; 2007 Feb; 32(2):439-49. PubMed ID: 17047667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological fMRI provides evidence for opioidergic modulation of discrimination of facial pain expressions.
    Zhao Y; Rütgen M; Zhang L; Lamm C
    Psychophysiology; 2021 Feb; 58(2):e13717. PubMed ID: 33140886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.
    Spagnolo PA; Ramchandani VA; Schwandt ML; Zhang L; Blaine SK; Usala JM; Diamond KA; Phillips MJ; George DT; Momenan R; Heilig M
    Alcohol Clin Exp Res; 2014 Dec; 38(12):3024-32. PubMed ID: 25581657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweet taste pleasantness is modulated by morphine and naltrexone.
    Eikemo M; Løseth GE; Johnstone T; Gjerstad J; Willoch F; Leknes S
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3711-3723. PubMed ID: 27538675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
    Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
    Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery.
    Savulich G; Riccelli R; Passamonti L; Correia M; Deakin JF; Elliott R; Flechais RS; Lingford-Hughes AR; McGonigle J; Murphy A; Nutt DJ; Orban C; Paterson LM; Reed LJ; Smith DG; Suckling J; Tait R; Taylor EM; Sahakian BJ; Robbins TW; Ersche KD
    Transl Psychiatry; 2017 Mar; 7(3):e1054. PubMed ID: 28267152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of naltrexone supersensitivity during food-maintained responding enhances naltrexone's ability to reduce ethanol-maintained responding.
    Williams KL
    Alcohol Clin Exp Res; 2007 Jan; 31(1):39-47. PubMed ID: 17207100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
    Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection.
    Williams KL; Broadbridge CL
    Alcohol; 2009 Mar; 43(2):119-26. PubMed ID: 19251113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.
    Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J; Barker S; Lomnicka I; Waguespack M; Johnson MW; Griffiths RR; Riba J
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26874330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment.
    Doty P; Kirk JM; Cramblett MJ; de Wit H
    Drug Alcohol Depend; 1997 Aug; 47(2):109-16. PubMed ID: 9298332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.
    Ko MC; Butelman ER; Traynor JR; Woods JH
    J Pharmacol Exp Ther; 1998 May; 285(2):518-26. PubMed ID: 9580592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.